论文部分内容阅读
Objective LCNEC and SCLC are aggressive neuroendocrine carcinomas with overlap in clinical,histopathologic,morphologic and genomic features.Differential molecular features between the two subtypes have not been well elucidated,contributing the uncertainty for optimal clinical strategy for each subtype.